NASDAQ
0.48USD
+0.03 (+6.97%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
8.1M
P/E
—
EPS
—
Beta
2.05
52W range
0.162-2.75
Day range
0.40–0.48
Open
0.45
Prev close
0.45
Volume
1.6M
Avg volume
9.7M
Dividend
0.00
IPO
2023-03-21
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Mangoceuticals, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for MGRX: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
